Harmony Biosciences Reports Continued Momentum for Pitolisant 

Harmony Biosciences Holdings Inc reported business updates for the quarter ended March 31, noting continued momentum in its commercial business for Wakix (pitolisant), as well as in the advancement of its clinical development programs for pitolisant for the treatment of idiopathic hypersomnia. Wakix, a first-in-class medication approved by the US Food and Drug Administration (FDA)…

Read More

Sleep Health Trailblazer Receives National Sleep Foundation’s Lifetime Achievement Award

Max Hirshkowitz, PhD, has received the National Sleep Foundation’s (NSF) Lifetime Achievement Award. The Lifetime Achievement Award is the organization’s highest honor, recognizing an individual who has demonstrated exemplary leadership in the field of sleep health. The award celebrates the recipient’s connection to NSF’s non-profit, public health mission through their extensive professional contributions to the…

Read More